Kepos Capital LP Biovie Inc. Transaction History

Kepos Capital LP

  • $258 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$1.44 - $5.04 $777,600 - $2.72 Million
-540,000 Reduced 95.58%
25,000 $36,000
Q1 2022

May 13, 2022
SELL
$2.74 - $5.65 $164,400 - $339,000
-60,000 Reduced 9.6%
565,000 $2.67 Million
Q3 2021

Nov 12, 2021
BUY
$6.69 - $16.93 $4.18 Million - $10.6 Million
625,000 New
625,000 $4.18 Million

Others Institutions Holding BIVI

# of Institutions
57
Shares Held
4.79M
Call Options Held
17.2K
Put Options Held
27K
View Full List

About BIOVIE INC.

BIVI Quotes by TradingView
  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $36.2M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track This Portfolio

Track Kepos Capital LP Portfolio

Follow Kepos Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Kepos Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email